Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events.
Koch EAT, Petzold A, Dippel E, Erdmann M, Gesierich A, Gutzmer R, Hassel JC, Haferkamp S, Kähler KC, Kreuzberg N, Leiter U, Loquai C, Meier F, Meissner M, Mohr P, Pföhler C, Rahimi F, Schell B, Terheyden P, Thoms KM, Ugurel S, Ulrich J, Utikal J, Weichenthal M, Ziller F, Berking C, Heppt MV.
Koch EAT, et al. Among authors: meissner m.
Front Immunol. 2024 Jun 10;15:1395225. doi: 10.3389/fimmu.2024.1395225. eCollection 2024.
Front Immunol. 2024.
PMID: 38915414
Free PMC article.